Article info

This article has a correction. Please see:

Download PDFPDF
Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects

Authors

  1. Correspondence to:
    Giovanni Lapadula
    DIMIMP-Sezione di Reumatologia, Policlinico, Piazza G Cesare 11, 70124 Bari, Italy;g.lapadula{at}reumbari.uniba.it
View Full Text

Citation

Iannone F, Trotta F, Monteccuco C on behalf of GISEA (Gruppo Italiano per lo Studio delle Early Arthritis), et al
Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects

Publication history

  • Accepted June 29, 2006
  • First published July 12, 2006.
Online issue publication 
January 22, 2007

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.